Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Relief Therapeutics Announces Swissmedic Approval and Operation of New Good Manufacturing Practice-Compliant Laboratory 15.05.2023
Aurinia Pharmaceuticals (AUPH) Announces Swissmedic Approval of LUPKYNIS streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Aurinia Pharmaceuticals Inc. today announced that the Swiss Agency for Therapeutic Products has granted marketing authorization of LUPKYNIS® in combination with a background immunosuppressive. | May 2, 2023
EDMONTON, Alberta (BUSINESS WIRE) Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization of LUPKYNIS® (voclosporin) in combination with a background immunosuppressive therapy to treat adult.
U S –Swiss Mutual Recognition Agreement on Good Manufacturing Practices sidley.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sidley.com Daily Mail and Mail on Sunday newspapers.